U.S. General Merchandise and Department Stores Stock News

NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

QuidelOrtho (QDEL) Is Down 5.1% After Broad Russell Growth Index Removal - What's Changed

On 27 June 2026, QuidelOrtho Corporation (NasdaqGS: QDEL) was removed from several Russell growth and small-cap benchmarks, including the Russell 2000 Growth, Russell 2500 Growth, Russell 3000 Growth, and Russell 3000E Growth indices. This broad index removal can matter for investors because it often triggers benchmark-tracking funds to adjust their holdings, potentially reshaping trading volumes and the shareholder base. We’ll now examine how QuidelOrtho’s removal from multiple Russell...
NYSE:FNF
NYSE:FNFInsurance

3 US Insurance Stocks That Could Benefit If Interest Rates Stay Higher Longer

With the Federal Reserve divided on how many rate hikes may still be ahead and inflation sitting above the 2% target for five years, investors are rethinking which stocks are most exposed to higher-for-longer borrowing costs. One area drawing fresh attention is US insurance companies, where investment income and balance sheet strength can look very different when policy rates stay elevated. This article walks through three stocks from a US Insurance Companies screener that are closely tied to...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Stock Could Be 44% Overvalued Following CTO Appointment

Dave stock has delivered an extremely strong three year return while the Excess Returns intrinsic value estimate currently points to the shares trading at a premium, and the broader valuation checks lean expensive rather than clearly cheap. Over the past three years, Dave has delivered a very large total return of roughly 7x, which naturally raises the bar for what counts as good value today. The appointment of Gopi Kuchimanchi as Chief Technology Officer may support expectations for further...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Should Viper’s New Shelf Registration and Index Additions Reshape the VNOM Investment Thesis?

Viper Energy, Inc. recently closed its August 26, 2025 shelf registration, covering US$156.57 million of Class A common stock, while also being added to the Russell 1000 Defensive and Russell 1000 Value-Defensive indices in late June 2026. This combination of fresh equity capacity and inclusion in widely followed defensive value indices may broaden Viper’s investor base and deepen liquidity. We’ll now examine how Viper’s addition to key Russell defensive indices may influence its investment...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

Enliven Therapeutics (ELVN) Fell Out Of Russell Indexes, But Is The Valuation Already Rich?

Enliven Therapeutics (ELVN) was recently removed from several Russell indexes, including the Russell Microcap and Russell 3000E group. This index reshuffle can influence index fund flows and short term trading dynamics for the stock. See our latest analysis for Enliven Therapeutics. Despite the index removals, Enliven Therapeutics has seen strong momentum recently, with a 30 day share price return of 51.17%, a year to date share price return of 227.16%, and a 1 year total shareholder return...
NasdaqGM:KRUS
NasdaqGM:KRUSHospitality

Kura Sushi USA (KRUS) Stock Q3 Profit Challenges Ongoing Unprofitable Narrative

Kura Sushi USA (KRUS) just reported Q3 2026 results with total revenue of US$85.9 million and basic EPS of US$0.03, alongside net income of US$0.4 million. This puts a spotlight on how its top line and earnings are tracking against expectations for a still unprofitable stock. The company has seen quarterly revenue move from US$73.5 million in Q1 2026 to US$80.0 million in Q2 2026 and now US$85.9 million in Q3 2026. Basic EPS shifted from a loss of US$0.25 in Q1 2026 and a loss of US$0.14 in...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Is Up 11.2% After Broad Russell Index Additions And AI Tool Launch – Has The Bull Case Changed?

In late June 2026, Figma, Inc. (NYSE:FIG) was added to multiple Russell indexes, including the Russell 1000, Russell Midcap, and several related value and completeness benchmarks, increasing its presence across major US equity indices. This broad index inclusion comes as Figma promotes new AI-powered design and workflow tools unveiled at its recent global user conference, potentially deepening its role in collaborative product development. Next, we’ll examine how this wave of index...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Alliant Energy’s Index Exit and Earnings Update Might Change The Case For Investing In LNT

Alliant Energy Corporation was removed from the Russell 1000 Dynamic Index in late June 2026, while also preparing to report its second‑quarter results with a management-hosted conference call at the end of July. The index removal may prompt mechanical portfolio rebalancing by index-tracking investors, potentially influencing trading volumes and ownership patterns around the upcoming earnings update. With Alliant Energy’s exit from the Russell 1000 Dynamic Index now in the past, we’ll assess...
NYSE:GXO
NYSE:GXOLogistics

GXO Logistics (GXO) Renews Castorama Partnership In France For Greener Automated Logistics

GXO Logistics (NYSE:GXO) has renewed its long-standing logistics partnership with Castorama in France. The relationship now spans roughly three decades and focuses on automation, digitization and sustainability. The renewed agreement includes efforts to cut the carbon footprint of operations and support Castorama’s omnichannel expansion. For investors tracking NYSE:GXO, the renewed Castorama contract in France adds another data point on how the company positions itself in contract logistics...
NYSE:ATEN
NYSE:ATENSoftware

A10 Networks (ATEN) Leaves Russell Indexes As Valuation Questions Build

What A10 Networks’ Index Removal Means for Investors A10 Networks (ATEN) has been removed from several Russell benchmarks, including the Russell 2000 Value, Russell Microcap, and Russell 3000E indices. This type of change can trigger meaningful trading as index-tracking funds rebalance. Broad index removal can lead to mechanical selling by passive funds that track these benchmarks. This activity can influence trading volumes and short term price behavior without necessarily reflecting any...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Merit Medical Systems (MMSI) Could Be 21% Below Fair Value Following Splashwire Recall

Why Merit Medical Systems stock is in focus after the Splashwire recall Merit Medical Systems (MMSI) is drawing attention after a voluntary Class II recall of over 5,000 Splashwire Hydrophilic Guide Wire units. The development is raising questions about quality controls, customer relationships, and any knock on effects for product availability. See our latest analysis for Merit Medical Systems. Merit Medical Systems' share price has recently been under pressure, with the year to date share...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Could Sportradar Group (SRAD) Be 24% Undervalued As Class Actions Raise Fresh Doubts?

Class action lawsuits accusing Sportradar Group (NasdaqGS:SRAD) of collaborating with black market gambling operators and misrepresenting compliance practices have quickly become a central factor for anyone assessing the stock today. See our latest analysis for Sportradar Group. Sportradar Group’s recent class action headlines sit against a mixed performance picture, with a 1 day share price return of 1.89% to US$16.16 and a 7 day share price return of 6.88%, but a year to date share price...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Power Integrations (POWI) Stock Still Looks Expensive On Fresh Analyst Target Hikes

Power Integrations stock has surged 78.2% year to date, yet based on current checks it still screens as expensive rather than a clear bargain. That creates a tension for investors between strong recent momentum and valuation metrics that point to a premium. The 78.2% gain year to date indicates that expectations for Power Integrations have reset sharply higher and may leave less room for disappointment. Recent analyst interest in Power Integrations' high power GaN portfolio and product...
NYSE:SKT
NYSE:SKTRetail REITs

Is Tanger (SKT) Stock Above Fair Value After A 151% Run?

Tanger stock has delivered a strong 151.2% return over the past five years. At a recent price of US$39.16, the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both suggest it no longer looks obviously cheap or clearly stretched. A 151.2% five year return means early shareholders have already seen substantial gains, so fresh buyers now need to pay closer attention to what they are getting for the current price. For a real estate focused company like Tanger, investor...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Plug Power (PLUG) Secures 50 MW Role In Australia’s Largest Green Hydrogen Project

Plug Power (NasdaqCM:PLUG) has been selected to supply 50 MW of electrolyzer capacity for Orica’s Hunter Valley Hydrogen Hub in Australia. The project has reached final investment decision with government backing, moving into execution as Australia’s largest green hydrogen development. The hub is intended to replace natural gas with renewable hydrogen in ammonia and ammonium nitrate production, creating a new industrial-scale use case for green hydrogen. Plug Power enters this contract with...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Company (ACHC) Rejoins Smaller Russell Indexes As Fair Value Questions Return

Index reshuffles have put Acadia Healthcare Company (ACHC) in focus, as the stock moves out of several Russell 1000 and midcap benchmarks and into the Russell 2000 and its value subset. See our latest analysis for Acadia Healthcare Company. The index reshuffle comes during a sharp shift in momentum for Acadia Healthcare Company, with the share price delivering a 21.41% 1 month return and 115.12% year to date, but a 59.01% decline in 3 year total shareholder return. This highlights how recent...
NYSE:EPAC
NYSE:EPACMachinery

Enerpac Tool Group (EPAC) Stock Margins Near 15% Reinforce Steady Industrial Narrative

Enerpac Tool Group (EPAC) has just posted its Q3 2026 numbers, with revenue of US$167.6 million and net income of US$29.8 million translating to basic EPS of US$0.58, against a trailing twelve month EPS base of US$1.78 and net income of US$93.3 million on revenue of US$634.1 million. The company has seen quarterly revenue move around the mid US$140 million to US$160 million range over recent periods, with basic EPS between roughly US$0.31 and US$0.58 per quarter. Earnings over the last year...
NasdaqGS:DGII
NasdaqGS:DGIICommunications

How Investors Are Reacting To Digi International (DGII) Bundling AI, Cloud Security And Hardware Into One Platform

In late June and early July 2026, Digi International announced the global availability of its ConnectCore 95 SMARC development kit and unveiled DANI, an embedded AI network-operations agent within Digi Remote Manager, while also shifting across multiple Russell growth indexes. Together, these moves highlight Digi’s effort to bundle hardware, security, lifecycle cloud services, and embedded AI into a single, standardized platform aimed at simplifying and scaling connected device deployments...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Stock Tests Bullish Narrative As Q3 Profitability Reaches 0.73 EPS

Penguin Solutions (PENG) opened its Q3 2026 update with total revenue of US$478.7 million and basic EPS of US$0.73, alongside trailing twelve month EPS of US$1.45 on revenue of about US$1.5 billion. This highlights the scale of its current earnings profile. The company has reported quarterly revenue rising from US$324.3 million in Q3 2025 to US$478.7 million in Q3 2026, while basic EPS has shifted from a small loss in Q3 2025 to US$0.73 this quarter. As a result, this reporting season is...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Animal Health (PAHC) Stock Still Looks Below Fair Value Despite A 143% Return

Phibro Animal Health stock has delivered a strong 143.3% return over the past 3 years, yet its current checks still suggest the shares look inexpensive relative to the fundamentals. Phibro Animal Health's 143.3% return over 3 years points to a stock that has already rewarded patient holders, which raises the bar for what counts as good value today. Future growth in animal health demand can support earnings and cash flow, while any pressure on input costs or pricing power may limit how much...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Settles Vaccine Patent Case With $950 Million Upfront Payment

Moderna (NasdaqGS:MRNA) has settled a long running patent dispute with Arbutus Biopharma and Genevant Sciences related to COVID-19 vaccine technology. The agreement includes a US$950 million upfront payment from Moderna to Arbutus and Genevant. The settlement covers lipid nanoparticle technology used in Moderna's COVID-19 vaccine and concludes multi year litigation. Moderna is a large mRNA therapeutics company best known for its COVID-19 vaccine, which relies on lipid nanoparticle delivery...
NYSE:UAMY
NYSE:UAMYMetals and Mining

Can United States Antimony (UAMY) Justify Its Price After New Capacity?

United States Antimony stock has logged a very large return over three years, yet the valuation checks point to a more muted picture where the Discounted Cash Flow (DCF) intrinsic value sits close to the current share price while market based multiples suggest the stock is expensive. Over the past three years, United States Antimony has returned about 18x, which puts extra attention on whether recent gains are already pricing in much of the good news. Commissioning of new smelting and...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax (EFX) Is Buying Círculo De Crédito To Grow In Mexico

Equifax (NYSE:EFX) has signed a definitive agreement to acquire Círculo de Crédito, a major credit bureau in Mexico. The deal is aimed at expanding Equifax's presence in Mexico's growing credit market. The acquisition is expected to add new data assets and create synergies across Equifax's Latin American operations. For Equifax, the Círculo de Crédito deal fits into its broader role as a global data, analytics, and technology company that supports lenders and other institutions. Mexico's...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Astrana Health (ASTH) Stock Trades At A Premium On Earnings But Strong On Returns

Astrana Health stock has delivered a strong 86.5% return over the past year, yet its valuation checks lean expensive rather than cheap, giving investors a mixed starting point when assessing the current price near US$46.28. An 86.5% one year return highlights how quickly sentiment has shifted, which raises the bar for what the business needs to deliver to justify the move. Recent optimism around value based care and expectations for stronger earnings can support the current share price, but...